@article{article, title  = {{Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden}},

 publisher = {{Oxford University Press (OUP)}},

 url = {{}},

 year = {{2020}},

 month = {{10}},

 author = {{Landmesser U and Lindgren P and Hagström E and van Hout B and Villa G and Pemberton-Ross P and Arellano J and Svensson ME and Sibartie M and Fonarow GC}},

 doi = {{10.1093/ehjqcco/qcaa072}},

 volume = {{8}},

 journal = {{European Heart Journal - Quality of Care and Clinical Outcomes}},

 issue = {{1}},

 pages = {{31-38}},

 note = {{Accessed on 2024/12/22}}}